NIAID study rules out high-dose clarithromycin for AIDS-related MAC.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000401:mortality; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use*; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis
D000900:Anti-Bacterial Agents; D017291:Clarithromycin